These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2212652)

  • 1. Self-binding antibodies (autobodies) form specific complexes in solution.
    Kaveri SV; Halpern R; Kang CY; Köhler H
    J Immunol; 1990 Oct; 145(8):2533-8. PubMed ID: 2212652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus.
    Kaveri SV; Kang CY; Köhler H
    J Immunol; 1990 Dec; 145(12):4207-13. PubMed ID: 2124238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of anti-idiotypic T cell lines propagated with syngeneic B lymphocytes. I. T cells bind intact idiotypes and discriminate between the somatic idiotypic variants in a manner similar to the anti-idiotopic antibodies.
    Cerny J; Smith JS; Webb C; Tucker PW
    J Immunol; 1988 Dec; 141(11):3718-25. PubMed ID: 3263431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies.
    Wittner MK; Bach MA; Köhler H
    J Immunol; 1982 Feb; 128(2):595-9. PubMed ID: 7033381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C; Gilbert D; Brard F; Tron F
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide.
    Kang CY; Brunck TK; Kieber-Emmons T; Blalock JE; Kohler H
    Science; 1988 May; 240(4855):1034-6. PubMed ID: 3368787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies of different specificities are self-binding: implication for antibody diversity.
    Kaveri SV; Halpern R; Kang CY; Köhler H
    Mol Immunol; 1991 Jul; 28(7):773-8. PubMed ID: 1906982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected.
    Claflin JL; Berry J
    J Immunol; 1988 Dec; 141(11):4012-9. PubMed ID: 3141511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reexpression of a T15 idiotope on variant immunoglobulins after the binding of another anti-idiotopic antibody.
    Strickland FM; Gleason JT; Cerny J
    J Immunol; 1987 Jun; 138(11):3868-72. PubMed ID: 3495576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of idiotope expression. IV. Genetic linkage of two D region-dependent T15 idiotopes to the IgH allotype.
    Cronkhite R; Schulze D; Cerny J
    J Immunol; 1989 Jan; 142(2):568-74. PubMed ID: 2562964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of heterologous antibodies specific for murine B-cell leukemia (BCL1) immunoglobulin by immunization with synthetic peptides homologous to heavy chain hypervariable regions.
    Smith LJ; Maloy WL; Braylan RC; Wakeland EK
    Cancer Res; 1985 Dec; 45(12 Pt 1):6119-23. PubMed ID: 3933821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.
    Geltner D; Franklin EC; Frangione B
    J Immunol; 1980 Oct; 125(4):1530-5. PubMed ID: 6774023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.
    Feeney AJ; Clarke SH; Mosier DE
    J Immunol; 1988 Aug; 141(4):1267-72. PubMed ID: 3135325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
    Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
    J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    Glennie MJ; McBride HM; Worth AT; Stevenson GT
    J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies.
    Haegert DG; Timm M
    Immunology; 1983 Nov; 50(3):447-59. PubMed ID: 6195097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
    Nicoletti C
    Exp Mol Pathol; 1995 Apr; 62(2):99-108. PubMed ID: 8549700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.